Center for Global Health R&D Policy Assessment

Follow us on:

Blogs tagged: India

Aarthi Rao
Posted by Aarthi Rao
May 16 2012

India’s Role in Global Health R&D

Insights from the Center’s latest Draft Report

Indian pharmaceutical and biotechnology industry’s face a rapidly evolving policy environment. Recent changes in the intellectual property regime, price controls, debates about compulsory licensing and other discussions of access to medicines place Indian firms squarely in the global eye. In the midst of this international attention, Indian firms have continued to be important players in providing low-cost access to medicines and other technologies needed around the world and are now focusing on expanding their reach to new products and regions.

Aarthi Rao
Posted by Aarthi Rao
May 16 2012

India’s Role in Global Health R&D

Insights from the Center’s latest Draft Report

Indian pharmaceutical and biotechnology industry’s face a rapidly evolving policy environment. Recent changes in the intellectual property regime, price controls, debates about compulsory licensing and other discussions of access to medicines place Indian firms squarely in the global eye. In the midst of this international attention, Indian firms have continued to be important players in providing low-cost access to medicines and other technologies needed around the world and are now focusing on expanding their reach to new products and regions.

Aarthi Rao
Posted by Aarthi Rao
Mar 22 2012

India’s Role in Solving the Curious Case of Diagnostics

Reflections on the recent conference in India on developing affordable diagnostics

Compared to drugs and vaccines, diagnostics are often overlooked as a critical health technology. Even though they don’t directly treat disease or confer immunization, they play a number of important roles in controlling disease. Some of these roles were pointed out at the “International Conference on Technological Challenges in Developing Affordable In-Vitro Molecular Diagnostics” which took place in Navi Mumbai this past week. The conference brought together top academics, policymakers and companies from within and outside India to discuss the latest advancements in diagnostics research.

Aarthi Rao
Posted by Aarthi Rao
Sep 16 2011

Point-of-Care Diagnostics for TB—The Devil’s in the Details

Reflections from recent conference, "TB Diagnostics in India: From importation and imitation to innovation"

Recently, I attended a conference in Bangalore, “TB Diagnostics in India: From importation and imitation to innovation” that brought together a diverse group that included public researchers, firms, venture capitalists, international donors and others to discuss the need for better TB diagnostics and the role that Indian firms might play in developing them.

Nora Engel
Posted by Nora Engel
Sep 13 2011

Challenges for Innovation in TB Diagnostics

Lessons from a recent conference in Bangalore, India

A guest blog by Nora Engel and Madhukar Pai

Paul Wilson
Posted by Paul Wilson
Sep 30 2010

Vaccines for the Poor: High Hopes in Hyderabad

The Role of Developing Country Vaccine Manufacturers in Global Health

Two weeks ago I traveled to Hyderabad, India, to attend the annual meeting of the Developing Country Vaccine Manufacturers Network (DCVMN).

This unusual alliance brings together vaccine companies in India, China, Brazil and a number of other mostly middle-income countries. Vaccine manufacturing in these countries is not new—many countries have long had factories, often state-owned, that produced basic vaccines for government immunization programs.